Monument Therapeutics

Private

ManchesterHealthcare & Life Scienceshttps://monumenttx.com/

Last Round

VC Round

Feb 25, 2025

Est. Valuation

$10.91M

Total Funding Raised

$3.64M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Monument Therapeutics is a biotechnology company that develops novel drugs for serious diseases of the central nervous system by using proprietary digital biomarkers to identify patients with homogenous underlying neurobiology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Mental Health, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Application

Keywords

precision neurosciencedigital biomarkerspatient stratificationCNS drug developmentneurotherapeuticsschizophrenia treatmentneurotechAI patient stratificationCognitive Impairment Associated with SchizophreniaCIASstratified medicineclinical trial optimizationneuroinflammationpostoperative cognitive dysfunctionfixed-dose combination drug

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Monument Therapeutics Comparables

Compare Monument Therapeutics with similar companies based on industry and business-model similarity.

Monument Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Monument Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Feb 25, 2025
VC Round	Oct 15, 2024
VC Round	Apr 18, 2024
Seed	Jul 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Jenny Barnett

CEO

Executive Team

Monument Therapeutics Investors

Notable investors and investment history

Monument Therapeutics investors
Investor	Rounds
ACF Investors	VC Round
Cambridge Angels	VC Round
o2h ventures	Seed, VC Round
Innovate UK	VC Round
Catapult Ventures	Seed
Neo Kuma Ventures	Seed
Wren Capital	Seed, VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 18, 2026
Monthly visitors grew 56% MoM, from 2.6K to 4K.
Apr 21, 2026
Monthly visitors grew 2328% MoM to 5.4K.

View all signals

Monument Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Monument Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Monument Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersManchester

Employee Range7

Year Founded2021

Last FundingFeb 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.